Royalty Pharma plc - Class A Ordinary Shares (RPRX) Covered Calls

Repros Therapeutics Inc. is development stage biopharmaceutical company focused on the development of oral small molecule drugs for major unmet medical needs.

You can sell covered calls on Royalty Pharma plc - Class A Ordinary Shares to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for RPRX (prices last updated Fri 4:16 PM ET):

Royalty Pharma plc - Class A Ordinary Shares (RPRX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
25.70 +0.12 25.34 25.70 3.8M 10 15
Covered Calls For Royalty Pharma plc - Class A Ordinary Shares (RPRX)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 20 25 1.10 24.60 1.6% 16.2%
Jan 17 25 1.55 24.15 3.5% 20.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Repros Therapeutics, Inc. operates as a biopharmaceutical company, which focuses on the development of new drugs to treat hormonal and reproductive system disorders. The company's current product pipeline consists of Androxal, Proellex, Vasomax and Z-Max. Repros Therapeutics was founded on August 20, 1987 and is headquartered in Woodlands, TX.